Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Huchet

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Biochemistry|November 26, 1999
Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaksC Bailly, A Lansiaux, L Dassonneville, et al.
Anti-Cancer Drug Design|January 5, 2002
A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38C Bailly, W Laine, B Baldeyrou, et al.
Journal of Cardiovascular Pharmacology|September 1, 1984
Urethane interferes with the alpha 2-agonist guanfacineN D Moore, M Chadelaud, A M Huchet, et al.
Neurology|August 1, 1987
Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neuronsC E Henderson, S L Hauser, M Huchet, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
BN 80927: a novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase IIO Lavergne, J Harnett, A Rolland, et al.
Anti-Cancer Drugs|March 29, 2001
The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poisonD Demarquay, M Huchet, H Coulomb, et al.
Neurology|December 1, 1986
Immunoblot analysis of circulating antibodies against muscle proteins in amyotrophic lateral sclerosis and other neurologic diseasesS L Hauser, P A Cazenave, O Lyon-Caen, et al.
Nature|May 11, 1999
Reduced antinociception in mice lacking neuronal nicotinic receptor subunitsL M Marubio, M del Mar Arroyo-Jimenez, M Cordero-Erausquin, et al.
Journal of Medicinal Chemistry|June 8, 2000
Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecinsO Lavergne, D Demarquay, C Bailly, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Biochemistry|November 26, 1999
Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaksC Bailly, A Lansiaux, L Dassonneville, et al.
Anti-Cancer Drug Design|January 5, 2002
A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38C Bailly, W Laine, B Baldeyrou, et al.
Journal of Cardiovascular Pharmacology|September 1, 1984
Urethane interferes with the alpha 2-agonist guanfacineN D Moore, M Chadelaud, A M Huchet, et al.
Neurology|August 1, 1987
Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neuronsC E Henderson, S L Hauser, M Huchet, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
BN 80927: a novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase IIO Lavergne, J Harnett, A Rolland, et al.
Anti-Cancer Drugs|March 29, 2001
The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poisonD Demarquay, M Huchet, H Coulomb, et al.
Neurology|December 1, 1986
Immunoblot analysis of circulating antibodies against muscle proteins in amyotrophic lateral sclerosis and other neurologic diseasesS L Hauser, P A Cazenave, O Lyon-Caen, et al.
Nature|May 11, 1999
Reduced antinociception in mice lacking neuronal nicotinic receptor subunitsL M Marubio, M del Mar Arroyo-Jimenez, M Cordero-Erausquin, et al.
Journal of Medicinal Chemistry|June 8, 2000
Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecinsO Lavergne, D Demarquay, C Bailly, et al.
Pageof 6